Privacy · App ComparisonIs Your Free Medication App Actually Free — and Who Actually Owns It?
Australia 2026.
Last reviewed July 2026 · General information only, not medical advice
30-day free trial · Works with any Australian pharmacy
Managing medications for your whole family? MediRemind keeps every person's scripts, repeats and reminders separate — on one phone, with no shared accounts. Free to download. Try MediRemind free for 30 days.
This article explains two different commercial models for medication apps. It is published by MediRemind. We have tried to be factually accurate and balanced — including acknowledging where pharmacy-linked apps offer advantages MediRemind does not. Information about other apps reflects publicly available sources as of July 2026. Verify directly with any app before switching.
"Free" is one of the most powerful words in software. But in the world of Australian medication apps, "free" usually means something specific: a pharmacy is funding the service instead of you.
That is worth understanding. But there is a second question Australian patients rarely think to ask: who owns the company behind the app?
In 2025, the most widely used medication app in Australia changed hands. Its Australia and New Zealand operations were acquired by Jonas Software ANZ — a subsidiary of Constellation Software Inc., a company listed on the Toronto Stock Exchange in Canada. Patients who downloaded that app years ago may not be aware that the company receiving their data has changed.
This is not an argument against free apps or pharmacy-linked apps. It is a guide to understanding the two commercial models, the ownership question, and which option is likely to suit you better.
How Free Medication Apps Are Funded in Australia
Medication apps marketed as free to patients typically operate on a B2B model: the app company works with pharmacies, pharmacy groups or health networks who pay to access dispensing integrations, loyalty tools and patient-facing features. Because pharmacies are an important commercial customer in this model, product decisions can reflect pharmacy business interests alongside patient interests.
This arrangement can provide genuine value to patients — refill reminders, ordering tools and dispensing history in one place. The question is simply whether those features also happen to serve the pharmacy's interests, and what that means for features that do not.
The alternative model is simpler: the patient pays directly. No pharmacy pays anything. No pharmacy gets anything. Every product decision is made to serve the person taking the medication — not the business dispensing it.
In 2025, the landscape shifted further. Some of Australia's most widely used medication apps are now owned by overseas companies following acquisition by global software groups. Patients who downloaded these apps years ago may not be aware that the company receiving their data has changed.
Who Owns Your Medication App?
A question most Australian patients have never thought to ask: where is the company behind your medication app actually based — and who owns it?
For MediRemind, the answer is straightforward. It is built and owned by an Australian family in Perth, Western Australia. There is no parent company, no overseas investor and no acquisition in the background. The team that built the app is the team that owns it. All subscription revenue stays with an Australian family business.
For other apps, the answer is more complicated. In July 2025, the Australia and New Zealand operations of one of Australia's most widely used medication apps were acquired by Jonas Software ANZ — a subsidiary of Constellation Software Inc., a company listed on the Toronto Stock Exchange in Canada. This is confirmed via ASX market announcement dated July 2025.
This does not mean those apps are bad. It does mean the company that holds your prescription history and health data is now a subsidiary of a Canadian-listed global software group. Whether that matters to you depends on how you weigh data sovereignty, company accountability and ownership when making decisions about your health apps.
MediRemind's position on ownership is simple: we are an Australian family, we built this app for our family, and we own it outright. That is not going to change.
What the Commercial Model Means for Features
Once you understand the funding model, some common gaps in pharmacy-linked apps are easier to explain.
Some pharmacy-linked features may depend on whether your chosen pharmacy participates in that app's network. If you travel interstate, move suburb or your usual pharmacy leaves the network, some features may become unavailable or limited. The degree to which this affects you depends on the specific app and how you use it.
Many pharmacy-linked apps require you to create an account and connect it to a specific pharmacy before full features become available. This enables services such as ordering, refill reminders and pharmacy communications. A patient-funded app has no dispensing relationship to establish, so it can be useful from first open.
Paper prescriptions remain in use, and some patients may still need to organise both paper and electronic prescriptions. Pharmacy-linked apps are primarily built around electronic dispensing integrations, so paper script storage may not be a priority feature.
MediRemind can display a saved eScript token on your phone without mobile data. The pharmacy will still require its usual dispensing-system connection to retrieve and dispense the prescription. Apps that rely on live connections to pharmacy systems to retrieve your eScript may encounter difficulties in low-coverage areas — though this depends on how the specific app stores and retrieves token data.
Managing medications for a partner, child or elderly parent may require separate accounts in pharmacy-linked apps, depending on how that app handles family profiles. A patient-funded app can manage multiple profiles entirely on-device.
These are not necessarily failures — they are the natural result of building for a different primary customer. Understanding the model helps you decide whether it aligns with what you need from a medication app.
What Pharmacy-Funded and Overseas-Owned Apps Do Better
Pharmacy-funded apps have genuine advantages:
These are real, useful features. If your regular pharmacy participates and you are comfortable with the pharmacy-linked data model, these apps serve that use case well.
What the Commercial Model Means for Your Data
Medication data is among the most sensitive personal information you produce. It encodes your health conditions, your treatment history, your dosing changes over time. When reviewing any medication app, it is worth understanding what is collected, where it goes and who can access it.
Pharmacy-linked apps may process prescription or dispensing information to provide services such as medication lists, refill reminders, ordering and pharmacy communications. Patients should review each app's privacy policy to understand what information is collected, where it is stored and who can access it. The commercial relationship with pharmacies may mean that some data flows to pharmacy partners to enable those services — though the specifics vary significantly between apps.
Patient-funded apps have a different structural position. When a patient pays $4.99/month, the app company's entire revenue depends on the patient finding the app useful enough to keep paying — not on pharmacy relationships. That creates different product incentives and a different relationship with your data.
MediRemind does not connect to any pharmacy's dispensing system or send your prescription history to pharmacies or advertisers. Medication and eScript information is stored locally on your device. Limited account, subscription and diagnostic information may be processed to operate and support the app. See the eScripts Australia guide for more on how the Australian eScript system works and what data is involved.
Side-by-Side Comparison
| Question | Pharmacy-linked apps | MediRemind |
|---|---|---|
| Who primarily funds the service? | May be funded through participating pharmacies or commercial partners | User subscription |
| Must I select a specific pharmacy? | Depends on the app and feature | No |
| Can I store paper-script information? | Depends on the app | Yes |
| Can I display a saved eScript token without mobile data? | Depends on how the token is stored | Yes |
| Does it connect to pharmacy dispensing software? | Some do | No |
| Where is medication information stored? | Check the individual privacy policy | Primarily on your device |
| Can I manage family profiles? | Depends on the app | Yes |
Prefer medication management designed around you?
MediRemind works with any Australian pharmacy, stores medication information primarily on your device and supports eScripts, paper scripts and family profiles.
Download MediRemind Free30-day free trial · Cancel anytime
An Australian patient-first app that manages both eScripts and paper scripts, with separate profiles for every family member. 30-day free trial,
30-day free trial · Then from $4.99/month — less than one coffee
Your 30-day free trial begins in the app.
How to Choose the Right App for You
A pharmacy-linked free app may suit you well if you consistently use one pharmacy, your medications are all electronic, you are comfortable with the app's data arrangements, and reliable mobile connectivity is not an issue at the pharmacy counter.
A patient-funded app is likely a better fit if you want flexibility to use any pharmacy, you have paper prescriptions, you are managing medications for multiple family members, you prefer your medication data to stay on your device, or you are in a regional or low-coverage area where offline QR display matters.
The question to ask is not "which app has the most features?" It is "who paid for those features, and whose interests were they built for?"
The Bottom Line
Free medication apps are free because someone else is paying — and that someone is typically a pharmacy or commercial partner. That funding relationship can influence feature decisions: which pharmacies the app works with, what data arrangements are in place, how family profiles are handled, and whether offline use is supported.
None of this makes pharmacy-linked apps bad. It makes them rational products serving a particular model. If that model aligns with how you use your medication app, it may work perfectly well. If you move, travel, use paper scripts or want your medication data to stay on your phone, a patient-funded model may serve you better.
If you want to understand how to manage your eScripts more effectively, read the guide to managing eScripts in Australia.
Australian-owned. Built in Perth. Your data stays on your phone.
30-day free trial · Cancel anytime
Frequently Asked Questions
Yes. MediRemind Scripts is built and owned by Ovara Tech, an Australian family business registered in Nedlands, Western Australia (ABN 43 324 331 038). The app was built by a Perth father and son for their wife and mother, who manages multiple chronic medications. All subscription revenue stays with an Australian family business. There is no parent company, no overseas investor and no acquisition in the background.
Pharmacy-linked apps may process prescription or dispensing information to provide services such as medication lists, refill reminders, ordering and pharmacy communications. Patients should review each app's privacy policy to understand what information is collected, where it is stored and who can access it.
MediRemind is not tied to a pharmacy network. It stores the standard Australian eScript QR code on your device, which you can present at any pharmacy equipped to dispense Australian electronic prescriptions — Chemist Warehouse, Priceline, your local independent or any other. No partner pharmacy is required.
A pharmacy-linked app may be funded in part by pharmacies — so features may be shaped by pharmacy revenue, loyalty and dispensing considerations. A patient-funded app is paid for directly by the person taking the medication — so every feature decision is made to help that person manage their medications, with no competing pharmacy interest.
No. MediRemind does not share your medication data with pharmacies, pharmacy chains or advertisers. Medication and eScript data is stored locally on your device. Limited technical information — account details, subscription status, crash reports — may be processed by third-party services to operate the app. See the Privacy Policy for full details.